Related Experiment Video
Updated: Jul 15, 2025

A Mouse Model for Pathogen-induced Chronic Inflammation at Local and Systemic Sites
Published on: August 8, 2014
A possible role for proinflammatory activation via cGAS-STING pathway in atherosclerosis induced by accumulation of
Chiemi Sakai1, Keitaro Ueda1, Kohei Goda1
1Department of Cardiovascular Physiology and Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima City, Hiroshima, 734-8551, Japan.
Abstract:
DNA damage contributes to atherosclerosis. However, causative links between DNA double-strand breaks (DSBs) and atherosclerosis have yet to be established. Here, we investigated the role of DSBs in atherosclerosis using mice and vascular cells deficient in Ku80, a DSB repair protein. After 4 weeks of a high-fat diet, Ku80-deficient apolipoprotein E knockout mice (Ku80+/-ApoE-/-) displayed increased plaque size and DSBs in the aorta compared to those of ApoE-/- control. In the preatherosclerotic stages (two-week high-fat diet), the plaque size was similar in both the Ku80+/-ApoE-/- and ApoE-/- control mice, but the number of DSBs and mRNA levels of inflammatory cytokines such as IL-6 and MCP-1 were significantly increased in the Ku80+/-ApoE-/- aortas. We further investigated molecular links between DSBs and inflammatory responses using vascular smooth muscle cells isolated from Ku80 wild-type and Ku80+/- mice. The Ku80+/- cells displayed senescent features and elevated levels of inflammatory cytokine mRNAs. Moreover, the cytosolic DNA-sensing cGAS-STING pathway was activated in the Ku80+/- cells. Inhibiting the cGAS-STING pathway reduced IL-6 mRNA level. Notably, interferon regulatory factor 3 (IRF3), a downstream effector of the cGAS-STING pathway, was activated, and the depletion of IRF3 also reduced IL-6 mRNA levels in the Ku80+/- cells. Finally, DSBs accumulation in normal cells also activated the cGAS-STING-IRF3 pathway. In addition, cGAS inhibition attenuated DNA damage-induced IL-6 expression and cellular senescence in these cells. These results suggest that DSBs accumulation promoted atherosclerosis by upregulating proinflammatory responses and cellular senescence via the cGAS-STING (-IRF3) pathway.
Insights
DNA double-strand breaks (DSBs) accumulation promotes atherosclerosis. Ku80 deficiency increases DSBs, leading to inflammation and senescence via the cGAS-STING-IRF3 pathway, driving disease progression.
Area of Science:
- Cardiovascular Biology
- Molecular Biology
- Genetics
Background:
- Atherosclerosis is a complex inflammatory disease.
- DNA damage, specifically DNA double-strand breaks (DSBs), is implicated in disease pathogenesis.
- The precise mechanisms linking DSBs to atherosclerosis remain unclear.
Purpose of the Study:
- To investigate the causative role of DSBs in atherosclerosis.
- To elucidate the molecular pathways connecting DSBs to inflammation and senescence in vascular cells.
Main Methods:
- Utilized apolipoprotein E knockout (ApoE-/-) mice with targeted deficiency in the DSB repair protein Ku80 (Ku80+/-ApoE-/-).
- Analyzed atherosclerotic plaque development, DSB accumulation, and inflammatory cytokine expression in mouse aortas.
- Investigated the cGAS-STING-IRF3 pathway activation and cellular senescence in Ku80-deficient vascular smooth muscle cells.
Main Results:
- Ku80+/-ApoE-/- mice showed increased aortic DSBs and plaque size after high-fat diet compared to controls.
- Early-stage atherosclerosis revealed elevated DSBs and inflammatory cytokines (IL-6, MCP-1) in Ku80+/-ApoE-/- aortas.
- Ku80+/- vascular cells exhibited senescence, activated cGAS-STING-IRF3 pathway, and increased IL-6; cGAS or IRF3 inhibition reduced IL-6.
Conclusions:
- DSBs accumulation promotes atherosclerosis development and progression.
- The cGAS-STING-IRF3 pathway mediates pro-inflammatory responses and cellular senescence induced by DSBs.
- Targeting DSB repair or the cGAS-STING pathway may offer therapeutic strategies for atherosclerosis.
Related Concept Videos
Inflammation
DNA Damage can Stall the Cell Cycle
Atherosclerosis I: Introduction
GPCRs Regulate Adenylyl Cylase Activity
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction

